Advertisement

Brexanolone and postpartum depression: what does it have to do with GABA?

  • Ahmed NaguyEmail author
Letter to the Editor
  • 9 Downloads

Puerperal depression is a form of (major depressive disorder) MDD that is universally recognized. A meta-analysis (O’Hara and Swain 1996) showed a prevalence of 13% with most cases starting in the first 3 months postpartum. Particular at-risk groups include pregnant immigrant women (Zelkowitz et al. 2008), teenage pregnancy (Bayatpour et al. 1992), assisted conception (Hammarberg et al. 2008), and previous stillbirth (Turton et al. 2001) The Edinburgh Postnatal Depression Scale (EPDS) has been developed to detect mothers suffering from postnatal depression in primary healthcare settings (Cox et al. 1987). Exact neurobiology remains elusive. Possibly hormonal (gonadal steroids) fluctuations associated with childbirth induce depression in vulnerable women (Bloch et al. 2000) . Other mechanisms at play include dysregulation of HPA axis already present in pregnancy. A study has showed a direct association between blood levels of CRH in the second trimester and development of postnatal...

Notes

Compliance with ethical standards

Competing interests

Author declares no competing interests.

References

  1. Bayatpour M, Wells RD, Holford S (1992) Physical and sexual abuse as predictors of substance use and suicide among pregnant teenagers. J Adolesc Health 13(2):128–132CrossRefGoogle Scholar
  2. Benasi G, Guidi J, Offidani E, Balon R, Rickels K, Fava GA (2018) Benzodiazepines as a monotherapy in depressive disorders: a systematic review. Psychother Psychosom 87(2):65–74CrossRefGoogle Scholar
  3. Bielau H, Steiner J, Mawrin C et al (2007) Dysregulation of GABAergic neurotransmission in mood disorders: a post-mortem study. Ann N Y Acad Sci 1096:157–169CrossRefGoogle Scholar
  4. Bloch M, Schmidt PJ, Danaceau M et al (2000) Effects of gonadal steroids in women with history of postpartum depression. Am J Psychiatry 157(6):924–930CrossRefGoogle Scholar
  5. Cox JL, Holden JM, Sagovsky R (1987) Development of the 10-item Edinburgh Postnatal Depression Scale (EPDS). Br J Psychiatry 150:782–786CrossRefGoogle Scholar
  6. Gold BI, Bowers MB Jr, Roth RH et al (1980) GABA levels in CSF of patients with psychiatric disorders. Am J Psychiatry 137(3):362–364CrossRefGoogle Scholar
  7. Hammarberg K, Fisher JR, Wynter KH (2008) Psychological and social aspects of pregnancy, childbirth and early parenting after assisted conception: a systematic review. Hum Reprod Update 14(5):395–414CrossRefGoogle Scholar
  8. Hasler G, van der Veer JW, Tumonis T et al (2007) Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 64(2):193–200CrossRefGoogle Scholar
  9. Levinson AJ, Fitzgerald PB, Favalli G, Blumberger DM, Daigle M, Daskalakis ZJ (2010) Evidence of cortical inhibitory deficits in major depressive disorder. Biol Psychiatry 67(5):458–464CrossRefGoogle Scholar
  10. Lin LC, Sibille E (2015) Somatostatin, neuronal vulnerability and behavioural emotionality. Mol Psychiatry 20(3):377–387CrossRefGoogle Scholar
  11. Meltzer-Brody S, Colquhoun H, Riesenberg R, Epperson CN, Deligiannidis KM, Rubinow DR, Li H, Sankoh AJ, Clemson C, Schacterle A, Jonas J, Kanes S (2018) Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet. 392(10152):1058–1070CrossRefGoogle Scholar
  12. O’Hara MW, Swain AM (1996) Rates and risks of postpartum depression- a meta-analysis. Int Rev Psychiatry 8(1):37–54CrossRefGoogle Scholar
  13. Petty F, Kramer GL, Gullion CM, John Rush A (1992) Low plasma γ-aminobutyric acid levels in male patients with depression. Biol Psychiatry 32(4):354–363CrossRefGoogle Scholar
  14. Sanjuan J, Martin-Santos R, Garcia-Esteve L, Carot JM, Guillamat R, Gutierrez-Zotes A, Gornemann I, Canellas F, Baca-Garcia E, Jover M, Navines R, Valles V, Vilella E, de Diego Y, Castro JA, Ivorra JL, Gelabert E, Guitart M, Labad A, Mayoral F, Roca M, Gratacos M, Costas J, van Os J, de Frutos R (2008) Mood changes after delivery: role of the serotonin transporter gene. Br J Psychiatry 193(5):383–388CrossRefGoogle Scholar
  15. Seney ML, Tripp A, McCune S, A. Lewis D, Sibille E (2015) Laminar and cellular analyses of reduced gene expression in the subgenual anterior cingulated cortex in major depression. Neurobiol Dis 73:213–219CrossRefGoogle Scholar
  16. Turton P, Hughes P, Evans CDH, Fainman D (2001) Incidence, correlates and predictors of post-traumatic stress disorder in the pregnancy after stillbirth. Br J Psychiatry 178:556–560CrossRefGoogle Scholar
  17. Warner MD, Peabody CA, Whiteford HA et al (1998) Alprazolam as an antidepressant. J Clin Psychiatry 49(4):148–150Google Scholar
  18. Yim IS, Glynn LM, Dunkel-Schetter C et al (2009) Risk of postpartum depressive symptoms with elevated corticotrophin-releasing hormone in human pregnancy. Arch Gen Psychiatry 66(2):162–169CrossRefGoogle Scholar
  19. Zelkowitz P, Saucier JF, Wang T, Katofsky L, Valenzuela M, Westreich R (2008) Stability and change in depressive symptoms from pregnancy to two months postpartum in childbearing immigrant women. Arch Womens Ment Health 11(1):1–11CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Al-Manara CAP CentreKuwait Centre for Mental Health (KCMH)ShuwaikhKuwait

Personalised recommendations